Glomerulonephritis rapidly progressive

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Alentis Therapeutics AG Commercial
    LIXUDEBART
    2022-502184-38-00 7 countries 2025 n=51
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Alentis Therapeutics AG Commercial 1 Phase II 1
New trials by year
2025
1
← All indication landscapes